0001437749-22-021457.txt : 20220829 0001437749-22-021457.hdr.sgml : 20220829 20220829164535 ACCESSION NUMBER: 0001437749-22-021457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220113 FILED AS OF DATE: 20220829 DATE AS OF CHANGE: 20220829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guirakhoo Farshad CENTRAL INDEX KEY: 0001656602 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41058 FILM NUMBER: 221211737 MAIL ADDRESS: STREET 1: 39 CHESTNUT STREET CITY: MELROSE STATE: MA ZIP: 02176 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxxinity, Inc. CENTRAL INDEX KEY: 0001851657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862083865 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1717 MAIN STREET STREET 2: SUITE 3388 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (254) 244-5739 MAIL ADDRESS: STREET 1: 1717 MAIN STREET STREET 2: SUITE 3388 CITY: DALLAS STATE: TX ZIP: 75201 4 1 rdgdoc.xml FORM 4 X0306 4 2022-01-13 1 0001851657 Vaxxinity, Inc. VAXX 0001656602 Guirakhoo Farshad 1717 MAIN STREET SUITE 3388 DALLAS TX 75201 1 (Former) Chief Scientific Off. Class A common stock 2022-01-13 4 M 0 10000 0.57 A 10000 D Class A common stock 2022-07-29 4 M 0 20000 0.57 A 40000 D Class A common stock 2022-08-15 4 M 0 26005 0.57 A 66005 D Class A common stock 2022-08-22 4 M 0 2640 0.57 A 68645 D Stock option (right to buy) 0.57 2022-01-13 4 M 0 10000 0 D 2021-06-05 2031-03-01 Class A common stock 10000 116730 D Stock option (right to buy) 0.57 2022-07-29 4 M 0 20000 0 D 2021-06-05 2031-03-01 Class A common stock 20000 86730 D Stock option (right to buy) 0.57 2022-08-15 4 M 0 26005 0 D 2021-06-05 2031-03-01 Class A common stock 26005 60725 D Stock option (right to buy) 0.57 2022-08-22 4 M 0 2640 0 D 2021-06-05 2031-03-01 Class A common stock 2640 58085 D The Reporting Person's Form 4 filed on May 5, 2022 incorrectly reported that the Reporting Person owned 10,000 shares of Class A common stock after the transaction on May 3, 2022 but the Reporting Person then owned 20,000 shares of Class A common stock. These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period. The Reporting Person's Form 4 filed on May 5, 2022 incorrectly reported that the Reporting Person owned 116,730 of these stock options after the transaction on May 3, 2022 but the Reporting Person then owned 106,730 of these stock options. /s/ Rene Paula Molina, attorney-in-fact for Farshad Guirakhoo 2022-08-29